KMT2A

HGNC ID: 7132

Target Abstract:

Thioredoxin (Trxs) is a group of small molecules widely present in all living cells and is a key regulator of cellular REDOX balance. The mammalian Trx family has three members: TRX-1, TRX-2, and TrxL. Trx-1 is the only thioredoxin that exists outside the cell and is secreted by lymphocytes, hepatocytes, fibroblasts, and a variety of tumor cells. The concentration of Trx-1 in plasma can reach 6 nM. It is found mainly in the cytoplasm of the cell, with small amounts in the nucleus and places associated with the outer surface of the cell. Trx-1 expression is increased under various stress conditions such as hypoxia, elevated hydrogen peroxide concentration, photochemical oxidative stress, viral and bacterial infections. Biological functions of Trx-1 include growth factor activity, antioxidant properties, reduction-equivalent cofactors, and transcriptional regulation. The synovial tissue of rheumatoid arthritis patients has increased Trx-1 levels under oxidative stress conditions. Plasma Trx-1 levels correlate with disease severity, suggesting that Trx-1 can be used as a biomarker for pathological conditions.

KMT2A Target Infomation Overview

  • Target Symbol: KMT2A, lysine methyltransferase 2A
  • Gene Groups: PHD finger proteins; Zinc fingers CXXC-type; Lysine methyltransferases; Bromodomain containing; SET domain containing
  • Alias: TRX1; HRX; ALL-1; HTRX1; CXXC7; MLL1A; MLL1; ALL1; HTRX
  • Previous Names: MLL
  • Alias Names: Histone-lysine N-methyltransferase 2A; myeloid/lymphoid or mixed-lineage leukemia (trithorax (Drosophila) homolog); myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); lysine (K)-specific methyltransferase 2A; Trithorax-like protein; CXXC-type zinc finger protein 7; Acute lymphocytic 1

KMT2A, lysine methyltransferase 2A Target Infomation by Species

  • Human
  • Mouse
  • Rat

Human KMT2A Target Information

  • Target Symbol: KMT2A, lysine methyltransferase 2A
  • Alias:
    • ALL-1
    • CDK6/MLL fusion protein
    • CXXC-type zinc finger protein 7
    • CXXC7
    • FLJ11783
    • histone-lysine N-methyltransferase 2A
    • histone-lysine N-methyltransferase MLL
    • HRX
    • HTRX1
    • hypothetical protein FLJ11783
    • lysine (K)-specific methyltransferase 2A
    • lysine N-methyltransferase 2A
    • mixed lineage leukemia 1
    • MLL
    • MLL-AF4 der(11) fusion protein
    • MLL-AF9
    • MLL/GAS7
    • MLL/GAS7 fusion protein
    • MLL/GMPS fusion protein
    • MLL1
    • MLL1A
    • myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)
    • myeloid/lymphoid or mixed-lineage leukemia protein 1
    • TET1-MLL
    • trithorax-like protein
    • TRX1
    • WDSTS
    • zinc finger protein HRX
  • NCBI_Gene: 4297
  • UniProtKB: Q03164

Human KMT2A Predicted Functions

Enables several functions, including lysine-acetylated histone binding activity; protein homodimerization activity; and protein methyltransferase activity. Involved in several processes, including histone modification; positive regulation of transporter activity; and regulation of nucleobase-containing compound metabolic process. Located in cytosol and nucleoplasm. Part of MLL1 complex. Implicated in acute myeloid leukemia; cervical cancer; mixed phenotype acute leukemia; and non-Hodgkin lymphoma. Biomarker of prostate cancer.

Mouse Kmt2a Target Information

Mouse Kmt2a Predicted Functions

Enables DNA binding activity; chromatin binding activity; and histone methyltransferase activity (H3-K4 specific). Involved in several processes, including definitive hemopoiesis; regulation of gene expression; and regulation of histone modification. Acts upstream of or within several processes, including hematopoietic or lymphoid organ development; macromolecule methylation; and regulation of histone modification. Located in nucleus. Is expressed in several structures, including extraembryonic component; genitourinary system; hematopoietic system; nervous system; and retina. Used to study acute lymphoblastic leukemia and acute myeloid leukemia. Human ortholog(s) of this gene implicated in acute myeloid leukemia; cervical cancer; mixed phenotype acute leukemia; and non-Hodgkin lymphoma. Orthologous to human KMT2A (lysine methyltransferase 2A).

Rat Kmt2a Target Information

  • Target Symbol: Kmt2a, lysine methyltransferase 2A
  • Alias:
    • histone-lysine N-methyltransferase 2A
    • histone-lysine N-methyltransferase MLL
    • lysine (K)-specific methyltransferase 2A
    • Mixed-lineage leukemia (also acute lymphocytic leukemia 1 or trithorax Drosophila gene)
    • Mixed-lineage leukemia (also acute lymphocytic leukemia 1 or tritorax Drosophila gene)
    • Mll
    • Mll_mapped
    • Mll1
    • myeloid/lymphoid or mixed-lineage leukemia
    • myeloid/lymphoid or mixed-lineage leukemia (mapped)
    • myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)
    • myeloid/lymphoid or mixed-lineage leukemia 1
  • NCBI_Gene: 315606
  • UniProtKB: F1M0L3

Rat Kmt2a Predicted Functions

Predicted to enable protein C-terminus binding activity. Involved in several processes, including DNA metabolic process; animal organ regeneration; and cellular response to heat. Located in nucleus. Used to study high grade glioma; leiomyoma; and prostate carcinoma. Biomarker of colon cancer; kidney disease; mucositis; type 2 diabetes mellitus; and urinary bladder cancer. Human ortholog(s) of this gene implicated in Crohn’s disease; breast cancer; human immunodeficiency virus infectious disease; and pancreatic cancer. Orthologous to human MKI67 (marker of proliferation Ki-67).